Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Advanced and Targeted Drug Delivery Market to 2021 - Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

26 Jul, 2016, 13:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, July 26, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021" report to their offering.

Advanced and Targeted Drug Delivery Market to grow at a 10.4% CAGR to $319 billion by 2021 from $168 billion in 2016

The advanced and targeted drug delivery market is segmented and analysed through to 2021 with corresponding CAGR breakdown by:
- Technology (Nanoparticles, Polymers (micelles, dendrimers etc), Monoclonal antibodies, Gold nanoparticles-based drug delivery and imaging, Drug eluting stents)
- Geography (Global, USA, Europe, RoW)
- Therapeutic Area (Pulmonary, Ocular drug delivery, Ocular nano-based drug delivery implants, Drug Eluting Stents,
- Sub-Market Analysis (details below)

The monoclonal antibody market is further broken down and presented as the top selling mAbs by company, class and revenue through to 2021 with corresponding CAGR values. Specific figures are given in relation to Humira, Remicade, Avastin, Rituxan, Soliris, Herceptin, Kadcyla, Perjeta, Lucentis, Xgeva/Prolia, Stelara and Tysarbi.

The global market for nano-based targeted drug delivery is presented by the following sub-markets liposomes, polymers (micelles, dendrimers etc) and gold nano-particles through to 2021 with corresponding CAGR figures.

The global pulmonary drug delivery market is analysed and presented as metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers through 2021 with corresponding CAGR data. This market is also divided into the following geographical regions USA, Europe, RoW, Global through 2021 with corresponding CAGR analysis.

Key Questions Answered in this Report:

- What are the maximum drug release times reported for various nano-based drug carriers?
- What regulatory agencies are approving specific nanomedicines?
- How many liposome-based drugs are available in the market?
- How many stealth liposomes have been granted market approval?
- How many PEGylated liposomes are used for targeted drug delivery?
- Who are the leading players in liposome-based drug formulation?
- What are stimuli-responsive polymers?
- Who are the market leaders in polymer-based drugs?
- What dendrimer-based drugs are the commercially available for targeted delivery?
- What are the applications of inorganic nanoparticles in targeted drug deliver?
- Which companies are focusing on inorganic nanoparticles for targeted drug delivery?
- What are the applications of magnetic nanoparticles in drug delivery, diagnostic and imaging?
- What is the global market value of nanomedicines?
- What is the global market for nanomedicines by therapeutic areas?
- What is the global market for monoclonal antibodies by geography?
- What are the best-selling mAbs?
- What is the global market for major targeted delivery systems?

Key Topics Covered:

1.0 Introduction

2.0 Targeted Drug Delivery: An Overview

3.0 Targeted Drug Delivery and Nanomedicines: An Overview

4.0 Lipid-Based Targeted Drug Delivery Nanosystems

5.0 Polymer-Based Carriers for Targeted Drug Delivery

6.0 Polymeric Micelle/Co-Polymers for Targeted Drug Delivery

7.0 Dendrimer-Based Targeted Drug Delivery

8.0 Inorganic Nanoparticles for Targeted Drug Delivery

9.0 Cell-Based Systems for Targeted Delivery

10.0 Nucleic Acid/Peptide as Drug Carriers

11.0 Targeted Therapies by Indication: An Overview

12.0 Other Targeted Drug Delivery Technologies

13.0 Market Analysis to 2021

14.0 Selected Company Profiles

Companies Mentioned

- 3M Company
- Abbott Laboratories
- Ablynx NV
- Aciont Inc.
- Acrux
- Agilis Biotherapeutics LLC
- Aileron Therapeutics Inc.
- Alchemia Oncology Pty Ltd.
- Alkermes Pharma Ireland Ltd.
- Allergan Inc.
- Alnylam Pharmaceuticals
- AmpliPhi Biosciences
- Andros Pharmaceuticals Co., Ltd.
- Angiochem Inc.
- Antares Pharma Inc.
- Aposense Ltd.
- Applied Genetic Technologies Corp. (AGTC)
- Aptagen LLC
- Aradigm Corp.
- ArisGen SA
- Armagen Technologies Inc.
- Arrowhead Research Corp.
- Artificial Cell Technologies Inc.
- AsclepiX Therapeutics LLC
- Asklepios BioPharmaceutical Inc.
- Astellas Pharma Inc.
- Audentes Therapeutics Inc.
- Avalanche Biotechnologies Inc.
- Avita Medical Ltd.
- Azaya Therapeutics Inc.
- Bachem Americas Inc.
- Bayer Pharma AG
- BBB Therapeutics BV
- Bespak Europe Ltd.
- Bicycle Therapeutics Ltd.
- BigDNA Ltd.
- BIND Therapeutics Inc.
- BioDelivery Sciences International Inc.
- Bioject Medical Technologies Inc.
- BioZone Laboratories Inc.
- Camurus AB
- Celsion Corp.
- CeramiSphere Pty Ltd.
- Cerulean Pharma Inc.
- Chrysalis BioTherapeutics Inc.
- Copernicus Therapeutics Inc.
- Cornerstone Pharmaceuticals Inc.
- CureVac AG
- CytImmune Sciences Inc.
- DepoMed Inc.
- Dicerna Pharmaceuticals
- Dimension Therapeutics Inc.
- Dipexium Pharmaceuticals Inc.
- Discovery Laboratories Inc.
- DURECT
- EnGeneIC Ltd
- Ensysce Biosciences Inc.
- EryDel SpA
- EryTech Pharma
- Esperance Pharmaceuticals Inc.
- Exicure Inc.
- FIT Biotech Oy
- Flamel Technologies S.A.
- Generex Biotechnology Corp.
- Genetic Immunity Inc.
- Genus Pharmaceuticals Ltd.
- GenVec Inc.
- GlaxoSmithKline LLC
- Glide Pharmaceutical Technologies Ltd.
- Heron Therapeutics Inc.
- Hoffmann-LaRoche Inc.
- ICB International Inc.
- iCeutica Inc.
- ImmusanT Inc.
- InDex Pharmaceuticals AB
- Immune Design
- Immunocore Ltd.
- Inovio Pharmaceuticals
- Insite Vision Inc.
- Insmed Inc.
- Intezyne Technologies Inc.
- Keystone Nano Inc.
- Kowa Pharmaceuticals America Inc.
- LipimetiX Inc.
- LiPlasome Pharma ApS
- Lipocine Inc.
- Lipotek Pty Ltd.
- Living Cell Technologies Ltd.
- MagForce AG
- Mankind Pharma Ltd.
- Mersana Therapeutics Inc.
- Micochips Biotech Inc.
- Milo Biotechnology LLC
- miRagen Therapeutics Inc.
- Mirna Therapeutics Inc.
- Miros Polymers Inc.
- Moderna Therapeutics Inc.
- MultiVir Inc.
- Mystic Pharmaceuticals Inc.
- Nanobiotix
- Nanocarrier Co., Ltd.
- Nanocopoeia Inc.
- NanoMedical Systems Inc.
- NanoOncology Inc. (PeptiMed Inc.)
- Nanospectra Biosciences Inc.
- Nano Precision Medical Inc.
- Nanotherapeutics Inc.
- nanoTherics Ltd
- Magnefect System
- NanoVector Inc.
- NanoViricides Inc.
- Nektar Therapeutics
- Neos Therapeutics Inc.
- NeXstar Pharmaceuticals Inc.
- NightstaRx Ltd.
- NOD Pharmaceuticals Inc.
- Nordic Nanovector ASA
- Novagali Pharma S.A.
- Novasorb Technology
- Novartis Pharmaceuticals Corp.
- Ocular Therapeutix Inc.
- Oncolytics Biotech Inc.
- Oxford Biomedica plc
- PDS Biotechnology Corp.
- PharmaIN Corp.
- PhaseRx Inc.
- Phico Therapeutics Ltd.
- PolyActiva Pty Ltd.
- PolyTherics Ltd.
- Presage Biosciences Inc.
- pSivida Corp.
- Pulmatrix Inc.
- Quark Pharmaceuticals Inc.
- Ra Pharmaceuticals Inc.
- RaNA Therapeutics Inc.
- RegeneRx Biopharmaceuticals Inc.
- Regenxbio Inc.
- Renova Therapeutics Inc.
- Replicor Inc.
- RetroSense Therapeutics LLC
- Rexahn Pharmaceuticals Inc.
- RJS Biologics LLC
- Roche Holding AG
- Sarfez Pharmaceuticals Inc.
- Savara Inc.
- Scintipharma Inc.
- Sequus Pharmaceuticals Inc.
- Serina Therapeutics Inc.
- Serpin Pharma LLC
- Silence Therapeutics PLC
- Silenseed Ltd.
- Sylentis SA
- SoluBest Ltd.
- Spark Therapeutics
- Spheringenics Inc.
- Suda Ltd.
- Supratek Pharma Inc.
- Taiwan Liposome Co. Ltd.
- TheraSource LLC
- Transgene SA
- Valeant Pharmaceuticals International Inc.
- Efudex
- Vect-Horus S.A.S.
- Vectura Group plc
- Vical Inc.
- Voyager Therapeutics Inc.
- WAVE Life Sciences Pvt. Ltd.
- Xel Pharmaceuticals
- Xenetic Biosciences
- Xigen SA
- Zealand Pharma AS
- Zozano Pharma Corp

For more information visit http://www.researchandmarkets.com/research/m3gm88/advanced_and

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.